JTCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yoshio Tsunezuka
Go Watanabe
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohta, Y.
Right arrow Articles by Watanabe, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohta, Y.
Right arrow Articles by Watanabe, G.
Related Collections
Right arrow Lung - cancer

J Thorac Cardiovasc Surg 2001;122:900-906
© 2001 The American Association for Thoracic Surgery

General Thoracic Surgery (GTS)

Can tumor size be a guide for limited surgical intervention in patients with peripheral non–small cell lung cancer? Assessment from the point of view of nodal micrometastasis

Yasuhiko Ohta, MDa,c, Makoto Oda, MDa, Jian Wu, MDa, Yoshio Tsunezuka, MDa, Minato Hiroshi, MDb, Akitaka Nonomura, MDb, Go Watanabe, MDa

From the Departments of Thoracic Surgerya and Pathology,b Kanazawa University, School of Medicine, and the Department of Thoracic Surgery,c Ishikawa Prefectural Central Hospital, Kanazawa, Japan.

Received for publication April 16, 2001. Revisions requested May 23, 2001; revisions received May 29, 2001. Accepted for publication June 1, 2001. Address for reprints: Yasuhiko Ohta, MD, Department of Thoracic Surgery, Kanazawa University, School of Medicine, Takara-machi 13-1, Kanazawa 920-8641, Japan (E-mail: yohta{at}med.kanazawa-u.ac.jp).

Abstract

Objective: We sought to determine the critical diameter of a peripheral non–small cell lung cancer tumor less than which no evidence of nodal micrometastasis is present.
Methods: Samples of 3081 lymph nodes from 181 patients with stage I peripheral lung cancer (155 with adenocarcinoma and 26 with squamous cell carcinoma) who had undergone complete resection with systematic lymphadenectomy were used in the study. In the samples immunohistochemical staining for cytokeratin was performed. The expression of vascular endothelial growth factor (VEGF) at primary sites was also immunohistochemically assessed.
Results: Nodal micrometastasis was detected in 44 patients. The mean tumor sizes were 2.2 ± 1.3 cm (range, 1.0-7.0 cm) in nodal micrometastasis–positive adenocarcinoma, 2.1 ± 0.9 cm (range, 0.5-6.0 cm) in nodal micrometastasis–negative adenocarcinoma, 4.8 ± 2.3 cm (range, 2.2-10.0 cm) in nodal micrometastasis–positive squamous cell carcinoma, and 3.2 ± 2.1 cm (range, 0-9.0 cm) in nodal micrometastasis–negative squamous cell carcinoma. The tumor size in the nodal micrometastasis–positive group tended to be greater than that in the nodal micrometastasis–negative group in squamous cell carcinomas, but there was no significant difference in adenocarcinomas. Nodal micrometastasis was not found in patients with squamous cell carcinoma of 2.0 cm or less in diameter. However, nodal micrometastasis was found in 20% (19/95) of the patients with adenocarcinoma of 1.1 to 2.0 cm in diameter and even in 4 of 11 patients with adenocarcinoma of 1.0 cm or less. Among the patients with nodal micrometastasis, survival of patients with vascular endothelial growth factor overexpression was worse than that of patients without it. The survival of patients with nodal micrometastasis without vascular endothelial growth factor overexpression was comparable with that of patients without nodal micrometastasis.
Conclusion: A limited surgical intervention without lymphadenectomy is validated for squamous cell carcinoma of 2.0 cm or less without pleural involvement. In adenocarcinoma the tumor size itself is not a reliable guide for nodal micrometastasis status. In patients with nodal micrometastasis with vascular endothelial growth factor overexpression, the risk of systemic disease should be considered.




This article has been cited by other articles:


Home page
 Acta RadiolHome page
K. Takahashi, T. Sasaki, B. Nabaa, E. J. van Beek, W. Stanford, and T. Aburano
Pulmonary lymphatic drainage to the mediastinum based on computed tomographic observations of the primary complex of pulmonary histoplasmosis
Acta Radiologica, March 1, 2012; 53(2): 161 - 167.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. E. Billmeier, J. Z. Ayanian, A. M. Zaslavsky, D. R. Nerenz, M. T. Jaklitsch, and S. O. Rogers
Predictors and Outcomes of Limited Resection for Early-Stage Non-Small Cell Lung Cancer
J Natl Cancer Inst, November 2, 2011; 103(21): 1621 - 1629.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. J. Schuchert, A. Kilic, A. Pennathur, K. S. Nason, D. O. Wilson, J. D. Luketich, and R. J. Landreneau
Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer
Ann. Thorac. Surg., June 1, 2011; 91(6): 1681 - 1688.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
A. Ruffato, S. Mattioli, S. Pileri, N. Daddi, F. D'Ovidio, V. Pilotti, and P. Tazzari
Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
Eur J Cardiothorac Surg, March 1, 2009; 35(3): 463 - 468.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. C. Lee, R. J. Korst, J. L. Port, Y. Kerem, A. L. Kansler, and N. K. Altorki
Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size
J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1382 - 1388.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
A. Ebihara, H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Uno, I. Kuwahira, and K. Eguchi
Characteristics of Advantages of Positron Emission Tomography over Computed Tomography for N-staging in Lung Cancer Patients
Jpn. J. Clin. Oncol., November 1, 2006; 36(11): 694 - 698.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Ketchedjian, B. D.T. Daly, H. C. Fernando, L. Florin, C. J. Hunter, D. M. Morelli, and R. J. Shemin
Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 544 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. Ohta, Y. Shimizu, H. Minato, I. Matsumoto, M. Oda, and G. Watanabe
Results of Initial Operations in Non-Small Cell Lung Cancer Patients With Single-Level N2 Disease
Ann. Thorac. Surg., February 1, 2006; 81(2): 427 - 433.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
X. T. Wang, W. Sienel, S. Eggeling, C. Ludwig, E. Stoelben, J. Mueller, C. A. Klein, and B. Passlick
Detection of disseminated tumor cells in mediastinoscopic lymph node biopsies and lymphadenectomy specimens of patients with NSCLC by quantitative RT-PCR
Eur J Cardiothorac Surg, July 1, 2005; 28(1): 26 - 32.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S.-i. Takeda, S. Fukai, H. Komatsu, E. Nemoto, K. Nakamura, M. Murakami, and Japanese National Chest Hospital Study Group
Impact of Large Tumor Size on Survival After Resection of Pathologically Node Negative (pN0) Non-Small Cell Lung Cancer
Ann. Thorac. Surg., April 1, 2005; 79(4): 1142 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. Higashi, K. Ito, Y. Hiramatsu, T. Ishikawa, T. Sakuma, I. Matsunari, G. Kuga, K. Miura, T. Higuchi, H. Tonami, et al.
18F-FDG Uptake by Primary Tumor as a Predictor of Intratumoral Lymphatic Vessel Invasion and Lymph Node Involvement in Non-Small Cell Lung Cancer: Analysis of a Multicenter Study
J. Nucl. Med., February 1, 2005; 46(2): 267 - 273.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Sakurai, H. Asamura, S.-i. Watanabe, K. Suzuki, and R. Tsuchiya
Clinicopathologic features of peripheral squamous cell carcinoma of the lung
Ann. Thorac. Surg., July 1, 2004; 78(1): 222 - 227.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
H. Vesselle, E. Turcotte, L. Wiens, and D. Haynor
Application of a Neural Network to Improve Nodal Staging Accuracy with 18F-FDG PET in Non-Small Cell Lung Cancer
J. Nucl. Med., December 1, 2003; 44(12): 1918 - 1926.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. T. Vollmer, J. E. Herndon II, J. D'Cunha, N. Z. Abraham, J. Solberg, M. Fatourechi, A. Maruska, J. A. Kern, M. R. Green, R. A. Kratzke, et al.
Immunohistochemical Detection of Occult Lymph Node Metastases in Non-Small Cell Lung Cancer: Anatomical Pathology Results from Cancer and Leukemia Group B Trial 9761
Clin. Cancer Res., November 15, 2003; 9(15): 5630 - 5635.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. Myrdal, M. Lambe, G. Gustafsson, K. Nilsson, and E. Stahle
Survival in primary lung cancer potentially cured by operation: influence of tumor stage and clinical characteristics
Ann. Thorac. Surg., February 1, 2003; 75(2): 356 - 363.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The American Association for Thoracic Surgery.